Latest Stock Split Details
Key information about Cardiff Oncology, Inc.'s most recent stock split
Split Date: 2019-02-20
Split Ratio: 1:6
Price Before Split: $0.48
Price After Split: $0.08
Developer API
Get CRDF split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/CRDF
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 6.00 times fewer shares (a 1:6 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Cardiff Oncology, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2019-02-20 | 1:6 | Yes | $0.48 | $0.08 |
| 2018-06-04 | 1:12 | Yes | $0.21 | $0.02 |
| 2012-05-30 | 1:6 | Yes | $0.59 | $0.10 |
| 2004-07-27 | 111:1 | No | $77682240.00 | $699840.00 |
About Cardiff Oncology, Inc.
Company overview and industry information
Cardiff Oncology, Inc. (CRDF) operates in the Biotechnology industry. The recent 1-for-6 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Cardiff Oncology, Inc. Summary